Zurich, Switzerland

Beat W Schäfer

This inventor holds 1 USPTO granted patent. Top assignee: Unversität Zürich. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Beat W Schäfer. Retrieved from https://idiyas.com/inventor/beat-w-schäfer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Beat W Schäfer: Innovator in Cancer Treatment

Introduction

Beat W Schäfer is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of medical research, particularly in the treatment of cancer. His innovative work focuses on developing effective therapies for challenging diseases.

Latest Patents

One of Beat W Schäfer's key patents is related to staurosporine derivatives for use in alveolar rhabdomyosarcoma. This invention pertains to the use of staurosporine derivatives in combination with ionizing radiation to delay the progression or treat proliferative diseases. Specifically, it addresses diseases associated with PAX/FKHR translocations, including PAX3/FKHR and PAX7/FKHR translocations, with a focus on solid tumor diseases such as sarcomas, particularly alveolar rhabdomyosarcoma. He holds 1 patent in this area.

Career Highlights

Beat W Schäfer is affiliated with Universität Zürich, where he conducts his research and development work. His academic background and professional experience have positioned him as a key figure in the field of cancer treatment innovations.

Collaborations

He has collaborated with notable colleagues, including Marco Wachtel and Ralf Amstutz, to advance research in his area of expertise.

Conclusion

Beat W Schäfer's contributions to cancer treatment through his innovative patents highlight the importance of research in developing effective therapies for complex diseases. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…